SOP for Use of Bioadhesive Polymers in Nanoparticle Formulations

SOP for Use of Bioadhesive Polymers in Nanoparticle Formulations

Standard Operating Procedure for Use of Bioadhesive Polymers in Nanoparticle Formulations

1) Purpose

This SOP outlines the procedure for incorporating bioadhesive polymers into nanoparticle formulations, enhancing their adhesion to biological tissues and improving the residence time of the therapeutic agent at the target site.

2) Scope

This SOP applies to personnel involved in the preparation and characterization of bioadhesive nanoparticle formulations used for drug delivery, particularly for mucosal or topical applications.

3) Responsibilities

  • Operators: Responsible for incorporating bioadhesive polymers into nanoparticle formulations as per this SOP.
  • QA: Ensures that bioadhesive formulations meet stability, adhesion, and release profile specifications.
See also  SOP for Incorporation of Peptides in Nanoparticle-Based Formulations

4) Procedure

4.1 Selection of Bioadhesive Polymers

4.1.1 Common Polymers

  • 4.1.1.1 Select bioadhesive polymers such as chitosan, polycarbophil, or alginate based on their compatibility with the nanoparticle and the intended route of administration.

4.2 Incorporation of Bioadhesive Polymers

4.2.1 Mixing Procedure

  • 4.2.1.1 Add the selected bioadhesive polymer to the nanoparticle formulation during or after the nanoparticle preparation process, ensuring thorough mixing for uniform coating or incorporation.

4.3 Testing for Adhesion and Stability

4.3.1 In Vitro Adhesion Testing

  • 4.3.1.1 Perform in vitro adhesion tests to measure the bioadhesive strength of the nanoparticles on mucosal or biological tissue models.

4.3.2 Stability Testing

  • 4.3.2.1 Conduct stability tests under various environmental conditions to ensure that the bioadhesive
nanoparticles maintain their properties during storage and use.

4.4 Storage

4.4.1 Storage Conditions

  • 4.4.1.1 Store bioadhesive nanoparticle formulations in sealed, sterile containers at 4°C to maintain stability and bioadhesion properties over time.

5) Abbreviations, if any

  • QA: Quality Assurance

6) Documents, if any

  • Bioadhesive Nanoparticle Formulation Logbook

7) References, if any

  • Guidelines for bioadhesive polymer use in nanoparticle formulations

8) SOP Version

Version 1.0

Annexure

Bioadhesive Nanoparticle Formulation Logbook Template

Date Batch Number Bioadhesive Polymer Used Concentration Adhesion Test Results Operator Initials QA Initials
DD/MM/YYYY Batch Number Polymer Name Concentration (w/v %) Pass/Fail Operator Name QA Name
           
See also  Nanoparticle Formulation : SOP for Preparation of Dendrimers for Drug Delivery

Related Posts